Current Journal Issue - Volume 23 Issue 3 (5 February 2012)
- Prescribing costs and patient safety: getting the balance right
- Tony Avery
- Published online on Feb 05, 2012
- DOI: 10.1002/psb.857 (p 6-8)
- Management of resistant Gram‐negative urinary tract infections
- Emily Macnaughton, Richard Brindle
- Published online on Feb 05, 2012
- DOI: 10.1002/psb.858 (p 13-18)
- Fingolimod: new oral treatment for relapsing‐remitting MS
- Steve Chaplin, Klaus Schmierer, Rachel Farrell
- Published online on Feb 05, 2012
- DOI: 10.1002/psb.859 (p 20-25)
- Recommended drug therapy for inflammatory bowel disease
- Kirstin Taylor, Mark Wilkinson
- Published online on Feb 05, 2012
- DOI: 10.1002/psb.860 (p 28-38)
- Neuromodulators for pain management in rheumatoid arthritis
- Published online on Feb 05, 2012
- DOI: 10.1002/psb.861 (p 39-39)
- National Prescribing Centre guidance on prescribing specials
- Steve Chaplin
- Published online on Feb 05, 2012
- DOI: 10.1002/psb.862 (p 40-41)
- Pfizer: world's largest research‐based drug company
- Joanna Lumb
- Published online on Feb 05, 2012
- DOI: 10.1002/psb.863 (p 42-43)
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- New Product Reviews
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Useful Websites
- Less Suitable Drugs
- Send Us Your Feedback
Advertising and Sponsorship
Other Journals
